Steven Cohen Cabaletta Bio, Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 667,275 shares of CABA stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
667,275Holding current value
$1.67 Million% of portfolio
0.01%Shares
8 transactions
Others Institutions Holding CABA
# of Institutions
127Shares Held
44.8MCall Options Held
202KPut Options Held
110K-
Black Rock Inc. New York, NY4.76MShares$11.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$10.3 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$9.18 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$7.59 Million0.03% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.9 Million2.34% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $72.5M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...